Shopping Cart
Remove All
Your shopping cart is currently empty
PDE4-IN-13 is a phosphodiesterase 4 (PDE4) inhibitor exhibiting anti-inflammatory and antioxidant activities, with an half maximal inhibitory concentration (IC50) value of 1.56 μM. It is used in the research of chronic obstructive pulmonary disease (COPD) [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | PDE4-IN-13 is a phosphodiesterase 4 (PDE4) inhibitor exhibiting anti-inflammatory and antioxidant activities, with an half maximal inhibitory concentration (IC50) value of 1.56 μM. It is used in the research of chronic obstructive pulmonary disease (COPD) [1]. |
| Targets&IC50 | PDE4:1.56 μM |
| In vitro | PDE4-IN-13 (Compound 6o) effectively reduces the production of TNF-α induced by lipopolysaccharide (LPS) in RAW264.7 macrophages as well as malondialdehyde (MDA) generation induced by Fe2+ in mouse lung homogenates. Additionally, PDE4-IN-13 exhibits excellent capabilities in reducing Fe3+ and chelating Fe2+ [1]. |
| In vivo | PDE4-IN-13 (Compound 6o), administered intraperitoneally at doses of 50 mg/kg and 100 mg/kg, significantly prevented the elevation of serum TNF-α levels in mice induced by LPS [1]. |
| Molecular Weight | 340.37 |
| Formula | C20H20O5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.